Risks and benefits of allergen immunotherapy.

U. Lüderitz-Püchel, B. Keller-Stanislawski, D. Haustein, Neubewertung des Risikos von Test- und Therapieallergenen Eine Analyse der UAW-Meldungen von 1991 bis 2000 Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz. ,vol. 44, pp. 709- 718 ,(2001) , 10.1007/S001030100201

P. A. Eng, M. Reinhold, HP. E. Gnehm, Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy. ,vol. 57, pp. 306- 312 ,(2002) , 10.1034/J.1398-9995.2002.1O3264.X

Maria Dolores Ibañez, Friedrich Kaiser, Roland Knecht, Alicia Armentia, Helmut Schöpfer, Bente Tholstrup, Albrecht Bufe, Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children Pediatric Allergy and Immunology. ,vol. 18, pp. 516- 522 ,(2007) , 10.1111/J.1399-3038.2007.00556.X

A. Des Roches, L. Paradis, J. Knani, A. Hejjaoui, H. Dhivert, P. Chanez, J. Bousquet, Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. ,vol. 51, pp. 430- 433 ,(1996) , 10.1111/J.1398-9995.1996.TB04643.X

A. Ameal, J. M. Vega-Chicote, S. Fernandez, A. Miranda, M. J. Carmona, M. C. Rondon, E. Reina, J. J. Garcia-Gonzalez, Double‐blind and placebo‐controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma Allergy. ,vol. 60, pp. 1178- 1183 ,(2005) , 10.1111/J.1398-9995.2005.00862.X

A. Magnan, M. Humbert, Is deficient tolerance the true paradigm for atopic diseases Clinical & Experimental Allergy. ,vol. 35, pp. 1507- 1510 ,(2005) , 10.1111/J.1365-2222.2005.02392.X

Ulrich Müller, Yvonne Hari, Emanuel Berchtold, Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. The Journal of Allergy and Clinical Immunology. ,vol. 107, pp. 81- 86 ,(2001) , 10.1067/MAI.2001.111852

Philippe Stock, Claudia Rolinck-Werninghaus, Ulrich Wahn, Eckard Hamelmann, The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis. BioDrugs. ,vol. 21, pp. 403- 410 ,(2007) , 10.2165/00063030-200721060-00007

H AMIN, G LISS, D BERNSTEIN, Evaluation of near-fatal reactions to allergen immunotherapy injections The Journal of Allergy and Clinical Immunology. ,vol. 117, pp. 169- 175 ,(2006) , 10.1016/J.JACI.2005.10.010

Linda Cox, Thomas A.E. Platts-Mills, Ira Finegold, Lawrence B. Schwartz, F. Estelle R. Simons, Dana V. Wallace, American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis Journal of Allergy and Clinical Immunology. ,vol. 120, pp. 1373- 1377 ,(2007) , 10.1016/J.JACI.2007.09.032